Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice
-
Quality control
- Retracted paper
- Contamination issues suspected
- Batch effect issues suspected
- Uncontrolled confounding suspected
- Results are suspect (various reasons)
- Tags applied
Experiment 1
Subjects
- Location of subjects
- China
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Mus musculus
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Constipation Constipation,Costiveness,Dyschezia,constipation
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Control ( Constipation mice without treatment )
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CMB1 ( Constipation mice treated with CMB with adhesion properties )
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB1, respectively, daily for 2 weeks
- Group 0 sample size Number of subjects in the control (unexposed) group
- 8
- Group 1 sample size Number of subjects in the case (exposed) group
- 8
Lab analysis
- Sequencing type
- 16S
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- V4
- Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
- Illumina
Statistical Analysis
- Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
- log transformation
- Statistical test
- ANOVA
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.05
Alpha Diversity
- Chao1 Abundance-based estimator of species richness
- increased
- Richness Number of species
- increased
- Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
- increased
Signature 1
Source: Fig. 3
Description: Relative abundance (%) of fecal microbial taxa at the genus level in constipated mice fed CMB
Abundance in Group 1: increased abundance in CMB1 ( Constipation mice treated with CMB with adhesion properties )
| NCBI | Quality Control | Links |
|---|---|---|
| Bifidobacterium |
Revision editor(s): Joiejoie
Experiment 2
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CMB2 (Constipation mice treated with CMB with no adhesion properties)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB2, respectively, daily for 2 weeks
Lab analysis
Statistical Analysis
Alpha Diversity
- Chao1 Abundance-based estimator of species richness
- unchanged
- Richness Number of species
- unchanged
- Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
- unchanged
Signature 1
Source: Fig. 3
Description: Relative abundance (%) of fecal microbial taxa at the genus level in constipated mice fed CMB
Abundance in Group 1: increased abundance in CMB2 (Constipation mice treated with CMB with no adhesion properties)
| NCBI | Quality Control | Links |
|---|---|---|
| Bifidobacterium |
Revision editor(s): Joiejoie
Experiment 3
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CMB1 ( Constipation mice treated with CMB with adhesion properties )
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB1, respectively, daily for 2 weeks
Lab analysis
Statistical Analysis
Alpha Diversity
- Chao1 Abundance-based estimator of species richness
- unchanged
- Richness Number of species
- unchanged
- Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
- unchanged
Signature 1
Source: Fig. 3
Description: Relative abundance (%) of fecal microbial taxa at the genus level in constipated mice fed CMB
Abundance in Group 1: decreased abundance in CMB1 ( Constipation mice treated with CMB with adhesion properties )
| NCBI | Quality Control | Links |
|---|---|---|
| Odoribacter |
Revision editor(s): Joiejoie
Experiment 4
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- CMB1 ( Constipation mice treated with CMB with adhesion properties )
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CMB2 (Constipation mice treated with CMB with no adhesion properties)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB2, respectively, daily for 2 weeks
Lab analysis
Statistical Analysis
Alpha Diversity
- Chao1 Abundance-based estimator of species richness
- unchanged
- Richness Number of species
- unchanged
- Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
- unchanged
Signature 1
Source: Fig. 3
Description: Relative abundance (%) of fecal microbial taxa at the genus level in constipated mice fed CMB
Abundance in Group 1: increased abundance in CMB2 (Constipation mice treated with CMB with no adhesion properties)
| NCBI | Quality Control | Links |
|---|---|---|
| Odoribacter |
Revision editor(s): Joiejoie
Experiment 5
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Control ( Constipation mice without treatment )
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CMB1 + Normal (Healthy mice)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- The CMB1 group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB1, respectively, daily for 2 weeks, while the normal group was given 0.25 mL of normal saline (NS) using intragastric administration once a day for 17 days
Lab analysis
Statistical Analysis
Alpha Diversity
- Chao1 Abundance-based estimator of species richness
- unchanged
- Richness Number of species
- unchanged
- Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
- unchanged
Signature 1
Source: Fig. 3
Description: Relative abundance (%) of fecal microbial taxa at the genus level in constipated mice fed CMB
Abundance in Group 1: increased abundance in CMB1 + Normal (Healthy mice)
| NCBI | Quality Control | Links |
|---|---|---|
| Parabacteroides |
Revision editor(s): Joiejoie
Experiment 6
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- CMB1 ( Constipation mice treated with CMB with adhesion properties )
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- All groups ( Normal, Control, CMB2 )
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- These groups were given 0.25 mL normal saline (NS) using intragastric administration once a day for 17 days, while the CMB2 group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB2, respectively, daily for 2 weeks.
Lab analysis
Statistical Analysis
Alpha Diversity
- Chao1 Abundance-based estimator of species richness
- unchanged
- Richness Number of species
- unchanged
- Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
- unchanged
Signature 1
Source: Fig. 3
Description: Relative abundance (%) of fecal microbial taxa at the genus level in constipated mice fed CMB
Abundance in Group 1: increased abundance in All groups ( Normal, Control, CMB2 )
| NCBI | Quality Control | Links |
|---|---|---|
| Lactobacillus |
Revision editor(s): Joiejoie
Experiment 7
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Control ( Constipation mice without treatment )
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CMB1 + Normal (Healthy mice)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- The CMB1 group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB1, respectively, daily for 2 weeks, while the normal group was given 0.25 mL of normal saline (NS) using intragastric administration once a day for 17 days
Lab analysis
Statistical Analysis
Alpha Diversity
- Chao1 Abundance-based estimator of species richness
- unchanged
- Richness Number of species
- unchanged
- Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
- unchanged
Signature 1
Source: Fig. 3
Description: Relative abundance (%) of fecal microbial taxa at the genus level in constipated mice fed CMB
Abundance in Group 1: decreased abundance in CMB1 + Normal (Healthy mice)
| NCBI | Quality Control | Links |
|---|---|---|
| Lactobacillus |
Revision editor(s): Joiejoie
Experiment 8
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CMB1 ( Constipation mice treated with CMB with adhesion properties )
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB1, respectively, daily for 2 weeks
Lab analysis
Statistical Analysis
Alpha Diversity
- Chao1 Abundance-based estimator of species richness
- unchanged
- Richness Number of species
- unchanged
- Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
- unchanged
Signature 1
Source: Fig. 3
Description: Relative abundance (%) of fecal microbial taxa at the genus level in constipated mice fed CMB
Abundance in Group 1: decreased abundance in CMB1 ( Constipation mice treated with CMB with adhesion properties )
| NCBI | Quality Control | Links |
|---|---|---|
| Clostridium |
Revision editor(s): Joiejoie
Experiment 9
Subjects
Lab analysis
Statistical Analysis
Alpha Diversity
- Chao1 Abundance-based estimator of species richness
- unchanged
- Richness Number of species
- unchanged
- Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
- unchanged
Signature 1
Source: Fig. 3
Description: Relative abundance (%) of fecal microbial taxa at the genus level in constipated mice fed CMB
Abundance in Group 1: increased abundance in CMB1 ( Constipation mice treated with CMB with adhesion properties )
| NCBI | Quality Control | Links |
|---|---|---|
| Clostridium |
Revision editor(s): Joiejoie
Experiment 10
Subjects
Lab analysis
Statistical Analysis
Signature 1
Source: Fig. 4
Description: Relative abundance (%) of fecal microbial taxa at the genus level in constipated mice fed CMB
Abundance in Group 1: decreased abundance in CMB1 ( Constipation mice treated with CMB with adhesion properties )
| NCBI | Quality Control | Links |
|---|---|---|
| unclassified Lachnospiraceae |
Revision editor(s): Joiejoie
Experiment 11
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CMB2 (Constipation mice treated with CMB with no adhesion properties)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB2, respectively, daily for 2 weeks
Lab analysis
Statistical Analysis
Signature 1
Source: Fig. 4
Description: Relative abundance (%) of fecal microbial taxa at the genus level in constipated mice fed CMB
Abundance in Group 1: decreased abundance in CMB2 (Constipation mice treated with CMB with no adhesion properties)
| NCBI | Quality Control | Links |
|---|---|---|
| unclassified Lachnospiraceae |
Revision editor(s): Joiejoie
Experiment 12
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CMB1 ( Constipation mice treated with CMB with adhesion properties )
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB1, respectively, daily for 2 weeks
Lab analysis
Statistical Analysis
Signature 1
Source: Fig. 4
Description: Relative abundance (%) of fecal microbial taxa at the genus level in constipated mice fed CMB
Abundance in Group 1: decreased abundance in CMB1 ( Constipation mice treated with CMB with adhesion properties )
| NCBI | Quality Control | Links |
|---|---|---|
| Oscillibacter |
Revision editor(s): Joiejoie
Experiment 13
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CMB2 (Constipation mice treated with CMB with no adhesion properties)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB2, respectively, daily for 2 weeks
Lab analysis
Statistical Analysis
Signature 1
Source: Fig. 4
Description: Relative abundance (%) of fecal microbial taxa at the genus level in constipated mice fed CMB
Abundance in Group 1: decreased abundance in CMB2 (Constipation mice treated with CMB with no adhesion properties)
| NCBI | Quality Control | Links |
|---|---|---|
| Oscillibacter |
Revision editor(s): Joiejoie
Experiment 14
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CMB1 ( Constipation mice treated with CMB with adhesion properties )
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB1, respectively, daily for 2 weeks
Lab analysis
Statistical Analysis
Signature 1
Source: Fig. 4
Description: Relative abundance (%) of fecal microbial taxa at the genus level in constipated mice fed CMB
Abundance in Group 1: decreased abundance in CMB1 ( Constipation mice treated with CMB with adhesion properties )
| NCBI | Quality Control | Links |
|---|---|---|
| Ruminococcus |
Revision editor(s): Joiejoie
Experiment 15
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CMB2 (Constipation mice treated with CMB with no adhesion properties)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB2, respectively, daily for 2 weeks
Lab analysis
Statistical Analysis
Signature 1
Source: Fig. 4
Description: Relative abundance (%) of fecal microbial taxa at the genus level in constipated mice fed CMB
Abundance in Group 1: decreased abundance in CMB2 (Constipation mice treated with CMB with no adhesion properties)
| NCBI | Quality Control | Links |
|---|---|---|
| Ruminococcus |
Revision editor(s): Joiejoie
Experiment 16
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CMB1 ( Constipation mice treated with CMB with adhesion properties )
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB1, respectively, daily for 2 weeks
Lab analysis
Statistical Analysis
Signature 1
Source: Fig. 4
Description: Relative abundance (%) of fecal microbial taxa at the genus level in constipated mice fed CMB
Abundance in Group 1: decreased abundance in CMB1 ( Constipation mice treated with CMB with adhesion properties )
| NCBI | Quality Control | Links |
|---|---|---|
| Sporobacter |
Revision editor(s): Joiejoie
Experiment 17
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CMB2 (Constipation mice treated with CMB with no adhesion properties)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB2, respectively, daily for 2 weeks
Lab analysis
Statistical Analysis
Signature 1
Source: Fig. 4
Description: Relative abundance (%) of fecal microbial taxa at the genus level in constipated mice fed CMB
Abundance in Group 1: decreased abundance in CMB2 (Constipation mice treated with CMB with no adhesion properties)
| NCBI | Quality Control | Links |
|---|---|---|
| Sporobacter |
Revision editor(s): Joiejoie
Experiment 18
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CMB1 ( Constipation mice treated with CMB with adhesion properties )
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB1, respectively, daily for 2 weeks
Lab analysis
Statistical Analysis
Signature 1
Source: Fig. 4
Description: Relative abundance (%) of fecal microbial taxa at the genus level in constipated mice fed CMB
Abundance in Group 1: decreased abundance in CMB1 ( Constipation mice treated with CMB with adhesion properties )
| NCBI | Quality Control | Links |
|---|---|---|
| Coprobacillus |
Revision editor(s): Joiejoie
Experiment 19
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CMB2 (Constipation mice treated with CMB with no adhesion properties)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB2, respectively, daily for 2 weeks
Lab analysis
Statistical Analysis
Signature 1
Source: Fig. 4
Description: Relative abundance (%) of fecal microbial taxa at the genus level in constipated mice fed CMB
Abundance in Group 1: decreased abundance in CMB2 (Constipation mice treated with CMB with no adhesion properties)
| NCBI | Quality Control | Links |
|---|---|---|
| Coprobacillus |
Revision editor(s): Joiejoie
Experiment 20
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CMB1 ( Constipation mice treated with CMB with adhesion properties )
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB1, respectively, daily for 2 weeks
Lab analysis
Statistical Analysis
Signature 1
Source: Fig. 5
Description: Relative abundance (%) of fecal microbial taxa at the genus level in constipated mice fed CMB
Abundance in Group 1: decreased abundance in CMB1 ( Constipation mice treated with CMB with adhesion properties )
| NCBI | Quality Control | Links |
|---|---|---|
| Turicibacter |
Revision editor(s): Joiejoie
Experiment 21
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CMB2 (Constipation mice treated with CMB with no adhesion properties)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB2, respectively, daily for 2 weeks
Lab analysis
Statistical Analysis
Signature 1
Source: Fig. 5
Description: Relative abundance (%) of fecal microbial taxa at the genus level in constipated mice fed CMB
Abundance in Group 1: decreased abundance in CMB2 (Constipation mice treated with CMB with no adhesion properties)
| NCBI | Quality Control | Links |
|---|---|---|
| Turicibacter |
Revision editor(s): Joiejoie
Experiment 22
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CMB1 ( Constipation mice treated with CMB with adhesion properties )
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB1, respectively, daily for 2 weeks
Lab analysis
Statistical Analysis
Signature 1
Source: Fig. 5
Description: Relative abundance (%) of fecal microbial taxa at the genus level in constipated mice fed CMB
Abundance in Group 1: increased abundance in CMB1 ( Constipation mice treated with CMB with adhesion properties )
| NCBI | Quality Control | Links |
|---|---|---|
| unclassified Helicobacteraceae |
Revision editor(s): Joiejoie
Experiment 23
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CMB2 (Constipation mice treated with CMB with no adhesion properties)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB2, respectively, daily for 2 weeks
Lab analysis
Statistical Analysis
Signature 1
Source: Fig. 5
Description: Relative abundance (%) of fecal microbial taxa at the genus level in constipated mice fed CMB
Abundance in Group 1: increased abundance in CMB2 (Constipation mice treated with CMB with no adhesion properties)
| NCBI | Quality Control | Links |
|---|---|---|
| unclassified Helicobacteraceae |
Revision editor(s): Joiejoie
Experiment 24
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CMB1 ( Constipation mice treated with CMB with adhesion properties )
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB1, respectively, daily for 2 weeks
Lab analysis
Statistical Analysis
Signature 1
Source: Fig. 5
Description: Relative abundance (%) of fecal microbial taxa at the genus level in constipated mice fed CMB
Abundance in Group 1: decreased abundance in CMB1 ( Constipation mice treated with CMB with adhesion properties )
| NCBI | Quality Control | Links |
|---|---|---|
| Anaeroplasma |
Revision editor(s): Joiejoie
Experiment 25
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CMB2 (Constipation mice treated with CMB with no adhesion properties)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB2, respectively, daily for 2 weeks
Lab analysis
Statistical Analysis
Signature 1
Source: Fig. 5
Description: Relative abundance (%) of fecal microbial taxa at the genus level in constipated mice fed CMB
Abundance in Group 1: increased abundance in CMB2 (Constipation mice treated with CMB with no adhesion properties)
| NCBI | Quality Control | Links |
|---|---|---|
| Anaeroplasma |
Revision editor(s): Joiejoie
Experiment 26
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CMB1 ( Constipation mice treated with CMB with adhesion properties )
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB1, respectively, daily for 2 weeks
Lab analysis
Statistical Analysis
Signature 1
Source: Fig. 5
Description: Relative abundance (%) of fecal microbial taxa at the genus level in constipated mice fed CMB
Abundance in Group 1: decreased abundance in CMB1 ( Constipation mice treated with CMB with adhesion properties )
| NCBI | Quality Control | Links |
|---|---|---|
| Prevotella |
Revision editor(s): Joiejoie
Experiment 27
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CMB2 (Constipation mice treated with CMB with no adhesion properties)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB2, respectively, daily for 2 weeks
Lab analysis
Statistical Analysis
Signature 1
Source: Fig. 5
Description: Relative abundance (%) of fecal microbial taxa at the genus level in constipated mice fed CMB
Abundance in Group 1: decreased abundance in CMB2 (Constipation mice treated with CMB with no adhesion properties)
| NCBI | Quality Control | Links |
|---|---|---|
| Prevotella |
Revision editor(s): Joiejoie
Experiment 28
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CMB1 ( Constipation mice treated with CMB with adhesion properties )
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB1, respectively, daily for 2 weeks
Lab analysis
Statistical Analysis
Signature 1
Source: Fig. 5
Description: Relative abundance (%) of fecal microbial taxa at the genus level in constipated mice fed CMB
Abundance in Group 1: decreased abundance in CMB1 ( Constipation mice treated with CMB with adhesion properties )
| NCBI | Quality Control | Links |
|---|---|---|
| Alistipes |
Revision editor(s): Joiejoie
Experiment 29
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CMB2 (Constipation mice treated with CMB with no adhesion properties)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB2, respectively, daily for 2 weeks
Lab analysis
Statistical Analysis
Signature 1
Source: Fig. 5
Description: Relative abundance (%) of fecal microbial taxa at the genus level in constipated mice fed CMB
Abundance in Group 1: decreased abundance in CMB2 (Constipation mice treated with CMB with no adhesion properties)
| NCBI | Quality Control | Links |
|---|---|---|
| Alistipes |
Revision editor(s): Joiejoie
Experiment 30
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CMB1 ( Constipation mice treated with CMB with adhesion properties )
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB1, respectively, daily for 2 weeks
Lab analysis
Statistical Analysis
Signature 1
Source: Fig. 6
Description: Relative abundance (%) of caecal microbial taxa at the genus level in constipated mice fed CMB.
Abundance in Group 1: increased abundance in CMB1 ( Constipation mice treated with CMB with adhesion properties )
| NCBI | Quality Control | Links |
|---|---|---|
| Bifidobacterium |
Revision editor(s): Joiejoie
Experiment 31
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- CMB1 ( Constipation mice treated with CMB with adhesion properties )
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CMB2 (Constipation mice treated with CMB with no adhesion properties)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB2, respectively, daily for 2 weeks
Lab analysis
Statistical Analysis
Experiment 32
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Normal ( Healthy mice )
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Control ( Constipation mice without treatment )
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This group was given 0.25 mL of normal saline (NS) using intragastric administration once a day for 17 days.
Lab analysis
Statistical Analysis
Signature 1
Source: Fig. 6
Description: Relative abundance (%) of caecal microbial taxa at the genus level in constipated mice fed CMB
Abundance in Group 1: increased abundance in Control ( Constipation mice without treatment )
| NCBI | Quality Control | Links |
|---|---|---|
| Adlercreutzia |
Revision editor(s): Joiejoie
Experiment 33
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Control ( Constipation mice without treatment )
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CMB1 ( Constipation mice treated with CMB with adhesion properties )
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB1, respectively, daily for 2 weeks
Lab analysis
Statistical Analysis
Signature 1
Source: Fig. 6
Description: Relative abundance (%) of caecal microbial taxa at the genus level in constipated mice fed CMB
Abundance in Group 1: increased abundance in CMB1 ( Constipation mice treated with CMB with adhesion properties )
| NCBI | Quality Control | Links |
|---|---|---|
| Bacteroides |
Revision editor(s): Joiejoie
Experiment 34
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CMB2 (Constipation mice treated with CMB with no adhesion properties)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB2, respectively, daily for 2 weeks
Lab analysis
Statistical Analysis
Signature 1
Source: Fig. 6
Description: Relative abundance (%) of caecal microbial taxa at the genus level in constipated mice fed CMB
Abundance in Group 1: increased abundance in CMB2 (Constipation mice treated with CMB with no adhesion properties)
| NCBI | Quality Control | Links |
|---|---|---|
| Bacteroides |
Revision editor(s): Joiejoie
Experiment 35
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Normal ( Healthy mice )
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Control ( Constipation mice without treatment )
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This group was given 0.25 mL of normal saline (NS) using intragastric administration once a day for 17 days.
Lab analysis
Statistical Analysis
Signature 1
Source: Fig. 6
Description: Relative abundance (%) of caecal microbial taxa at the genus level in constipated mice fed CMB
Abundance in Group 1: increased abundance in Control ( Constipation mice without treatment )
| NCBI | Quality Control | Links |
|---|---|---|
| Parabacteroides |
Revision editor(s): Joiejoie
Experiment 36
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Control ( Constipation mice without treatment )
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CMB1 + CMB2
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB1 and CMB2, respectively, daily for 2 weeks.
- Group 1 sample size Number of subjects in the case (exposed) group
- 16
Lab analysis
Statistical Analysis
Experiment 37
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Normal + Control + CMB1 ( All others )
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CMB2 (Constipation mice treated with CMB with no adhesion properties)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB2, respectively, daily for 2 weeks
- Group 0 sample size Number of subjects in the control (unexposed) group
- 24
- Group 1 sample size Number of subjects in the case (exposed) group
- 8
Lab analysis
Statistical Analysis
Experiment 38
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CMB1 ( Constipation mice treated with CMB with adhesion properties )
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB1, respectively, daily for 2 weeks
Lab analysis
Statistical Analysis
Signature 1
Source: Fig. 6
Description: Relative abundance (%) of caecal microbial taxa at the genus level in constipated mice fed CMB
Abundance in Group 1: increased abundance in CMB1 ( Constipation mice treated with CMB with adhesion properties )
| NCBI | Quality Control | Links |
|---|---|---|
| Unclassified S24-7Unclassified S24-7 |
Revision editor(s): Joiejoie
Experiment 39
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Control ( Constipation mice without treatment )
- Group 0 sample size Number of subjects in the control (unexposed) group
- 8
Lab analysis
Statistical Analysis
Signature 1
Source: Fig. 6
Description: Relative abundance (%) of caecal microbial taxa at the genus level in constipated mice fed CMB
Abundance in Group 1: decreased abundance in CMB1 ( Constipation mice treated with CMB with adhesion properties )
| NCBI | Quality Control | Links |
|---|---|---|
| Odoribacter |
Revision editor(s): Joiejoie
Experiment 40
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- CMB1 ( Constipation mice treated with CMB with adhesion properties )
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CMB2 (Constipation mice treated with CMB with no adhesion properties)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB2, respectively, daily for 2 weeks
Lab analysis
Statistical Analysis
Signature 1
Source: Fig. 6
Description: Relative abundance (%) of caecal microbial taxa at the genus level in constipated mice fed CMB
Abundance in Group 1: increased abundance in CMB2 (Constipation mice treated with CMB with no adhesion properties)
| NCBI | Quality Control | Links |
|---|---|---|
| Odoribacter |
Revision editor(s): Joiejoie
Experiment 41
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Normal ( Healthy mice )
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Control + CMB1
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This normal group was given 0.25 mL of normal saline (NS) using intragastric administration once a day for 17 days, while the CMB1 group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB1, respectively, daily for 2 weeks.
- Group 1 sample size Number of subjects in the case (exposed) group
- 16
Lab analysis
Statistical Analysis
Experiment 42
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- CMB1 ( Constipation mice treated with CMB with adhesion properties )
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CMB2 (Constipation mice treated with CMB with no adhesion properties)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB2, respectively, daily for 2 weeks
- Group 1 sample size Number of subjects in the case (exposed) group
- 8
Lab analysis
Statistical Analysis
Experiment 43
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Normal + Control
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CMB1 ( Constipation mice treated with CMB with adhesion properties )
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB1, respectively, daily for 2 weeks
- Group 0 sample size Number of subjects in the control (unexposed) group
- 16
Lab analysis
Statistical Analysis
Experiment 44
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CMB2 (Constipation mice treated with CMB with no adhesion properties)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB2, respectively, daily for 2 weeks
Lab analysis
Statistical Analysis
Experiment 45
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Control ( Constipation mice without treatment )
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CMB1 ( Constipation mice treated with CMB with adhesion properties )
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB1, respectively, daily for 2 weeks
- Group 0 sample size Number of subjects in the control (unexposed) group
- 8
Lab analysis
Statistical Analysis
Experiment 46
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Normal ( Healthy mice )
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Control ( Constipation mice without treatment )
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This group was given 0.25 mL of normal saline (NS) using intragastric administration once a day for 17 days.
Lab analysis
Statistical Analysis
Experiment 47
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Control ( Constipation mice without treatment )
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CMB1 ( Constipation mice treated with CMB with adhesion properties )
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB1, respectively, daily for 2 weeks
Lab analysis
Statistical Analysis
Experiment 48
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- CMB1 ( Constipation mice treated with CMB with adhesion properties )
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CMB2 (Constipation mice treated with CMB with no adhesion properties)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB2, respectively, daily for 2 weeks
Lab analysis
Statistical Analysis
Experiment 49
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Normal + Control + CMB2 ( All others )
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CMB1 ( Constipation mice treated with CMB with adhesion properties )
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB1, respectively, daily for 2 weeks
- Group 0 sample size Number of subjects in the control (unexposed) group
- 24
Lab analysis
Statistical Analysis
Experiment 50
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Normal + CMB1
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Control + CMB2
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This control group was given 0.25 mL of normal saline (NS) using intragastric administration once a day for 17 days, while the CMB2 group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB2, respectively, daily for 2 weeks.
- Group 0 sample size Number of subjects in the control (unexposed) group
- 16
- Group 1 sample size Number of subjects in the case (exposed) group
- 16
Lab analysis
Statistical Analysis
Experiment 51
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Control ( Constipation mice without treatment )
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CMB1 + CMB2
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- The CMB1 and CMB2 groups were intragastrically administered 0.25 mL of normal saline solution containing 4 × 1010 CFU/mL CMB1 or CMB2, respectively, daily for 2 weeks.
- Group 0 sample size Number of subjects in the control (unexposed) group
- 8
Lab analysis
Statistical Analysis
Experiment 52
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Not specified
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Not specified
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Not specified
- Group 0 sample size Number of subjects in the control (unexposed) group
- Not specified
- Group 1 sample size Number of subjects in the case (exposed) group
- Not specified
Lab analysis
Statistical Analysis
Experiment 53
Subjects
Lab analysis
Statistical Analysis
Experiment 54
Subjects
Lab analysis
Statistical Analysis
Experiment 55
Subjects
Lab analysis
Statistical Analysis
Experiment 56
Subjects
Lab analysis
Statistical Analysis
Experiment 57
Subjects
Lab analysis
Statistical Analysis
Experiment 58
Subjects
Lab analysis
Statistical Analysis
Experiment 59
Subjects
Lab analysis
Statistical Analysis
Experiment 60
Subjects
Lab analysis
Statistical Analysis
Experiment 61
Subjects
Lab analysis
Statistical Analysis
Experiment 62
Subjects
Lab analysis
Statistical Analysis
Experiment 63
Subjects
Lab analysis
Statistical Analysis
Experiment 64
Subjects
Lab analysis
Statistical Analysis
Experiment 65
Subjects
Lab analysis
Statistical Analysis
Experiment 66
Subjects
Lab analysis
Statistical Analysis
Experiment 67
Subjects
Lab analysis
Statistical Analysis
Experiment 68
Subjects
Lab analysis
Statistical Analysis
Experiment 69
Subjects
Lab analysis
Statistical Analysis
Experiment 70
Subjects
Lab analysis
Statistical Analysis
Experiment 71
Subjects
Lab analysis
Statistical Analysis
Experiment 72
Subjects
Lab analysis
Statistical Analysis
Experiment 73
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Normal + Control + BMC2
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- C-Normal + C-Control + C-CBM1
Lab analysis
Statistical Analysis
Experiment 74
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- C-Control + C-CBM1
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- C-CBM2
Lab analysis
Statistical Analysis
Experiment 75
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- BMC1 + BMC2
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- C-Normal
Lab analysis
Statistical Analysis
Experiment 76
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- C-Normal
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- BMC1 + BMC2
Lab analysis
Statistical Analysis
Signature 1
Source: Figure 9A
Description: The genus-level comparison of fecal samples and caecum content samples.
Abundance in Group 1: increased abundance in BMC1 + BMC2
| NCBI | Quality Control | Links |
|---|---|---|
| Anaeroplasma |
Revision editor(s): Mautin
Experiment 77
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- All others
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- BMC1 + C-CBM1
Lab analysis
Statistical Analysis
Signature 1
Source: Figure 9B
Description: The genus-level comparison of fecal samples and caecum content samples
Abundance in Group 1: increased abundance in BMC1 + C-CBM1
| NCBI | Quality Control | Links |
|---|---|---|
| Bacteroides |
Revision editor(s): Mautin
Experiment 78
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- BMC1
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- BMC2 + C-Normal + C-Control
Lab analysis
Statistical Analysis
Signature 1
Source: Figure 9C
Description: The genus-level comparison of fecal samples and caecum content samples.
Abundance in Group 1: decreased abundance in BMC2 + C-Normal + C-Control
| NCBI | Quality Control | Links |
|---|---|---|
| Bifidobacterium |
Revision editor(s): Mautin
Experiment 79
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Normal + Control + BMC2
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- C-Normal
Lab analysis
Statistical Analysis
Signature 1
Source: Figure 9D
Description: The genus-level comparison of fecal samples and caecum content samples.
Abundance in Group 1: increased abundance in C-Normal
| NCBI | Quality Control | Links |
|---|---|---|
| Clostridium |
Revision editor(s): Mautin
Experiment 80
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- C-Normal
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Normal + BMC2
Lab analysis
Statistical Analysis
Signature 1
Source: Figure 9E
Description: The genus-level comparison of fecal samples and caecum content samples.
Abundance in Group 1: decreased abundance in Normal + BMC2
| NCBI | Quality Control | Links |
|---|---|---|
| Dorea.Dorea. |
Revision editor(s): Mautin
Experiment 81
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- C-CBM2
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- C-Normal + C-Control + C-CBM1
Lab analysis
Statistical Analysis
Signature 1
Source: Figure 10 A
Description: The genus-level comparison of fecal samples and caecum content samples.
Abundance in Group 1: increased abundance in C-Normal + C-Control + C-CBM1
| NCBI | Quality Control | Links |
|---|---|---|
| unclassified Helicobacteraceae |
Revision editor(s): Mautin
Experiment 82
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- C-Normal + C-Control
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- C-CBM2
Lab analysis
Statistical Analysis
Signature 1
Source: Table 10 J
Description: The genus-level comparison of fecal samples and caecum content samples.
Abundance in Group 1: decreased abundance in C-CBM2
| NCBI | Quality Control | Links |
|---|---|---|
| Odoribacter |
Revision editor(s): Mautin
Experiment 83
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Normal + Control + BMC1 + BMC2
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- C-Normal + C-Control + C-CBM1
Lab analysis
Statistical Analysis
Signature 1
Source: Figure 11 A
Description: The genus-level comparison of fecal samples and caecum content samples.
Abundance in Group 1: increased abundance in C-Normal + C-Control + C-CBM1
| NCBI | Quality Control | Links |
|---|---|---|
| Oscillospira |
Revision editor(s): Mautin
Experiment 84
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- C-Normal + C-CBM1
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- BMC1 + BMC2
Lab analysis
Statistical Analysis
Signature 1
Source: Figure 11 B
Description: The genus-level comparison of fecal samples and caecum content samples.
Abundance in Group 1: decreased abundance in BMC1 + BMC2
| NCBI | Quality Control | Links |
|---|---|---|
| Oscillospira |
Revision editor(s): Mautin
Experiment 85
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- All others
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- C-Normal
Lab analysis
Statistical Analysis
Signature 1
Source: Figure 11 C
Description: The genus-level comparison of fecal samples and caecum content samples.
Abundance in Group 1: increased abundance in C-Normal
| NCBI | Quality Control | Links |
|---|---|---|
| Parabacteroides |
Revision editor(s): Mautin
Experiment 86
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Normal + Control + BMCI + BMC2
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- C-Normal + C-Control
Lab analysis
Statistical Analysis
Signature 1
Source: Figure 11 D
Description: The genus-level comparison of fecal samples and caecum content samples.
Abundance in Group 1: increased abundance in C-Normal + C-Control
| NCBI | Quality Control | Links |
|---|---|---|
| Rikenella |
Revision editor(s): Mautin
Experiment 87
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- C-Normal + C-Control
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- BMC2
Lab analysis
Statistical Analysis
Signature 1
Source: Figure 11 E
Description: The genus-level comparison of fecal samples and caecum content samples
Abundance in Group 1: decreased abundance in BMC2
| NCBI | Quality Control | Links |
|---|---|---|
| Rikenella |
Revision editor(s): Mautin
Experiment 88
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- All others
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- C-Control + C-CBM1
Lab analysis
Statistical Analysis
Signature 1
Source: Figure 11 F
Description: The genus-level comparison of fecal samples and caecum content samples.
Abundance in Group 1: increased abundance in C-Control + C-CBM1
| NCBI | Quality Control | Links |
|---|---|---|
| Ruminococcus |
Revision editor(s): Mautin
Experiment 89
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- C-Control + C-CBM1
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Normal + Control + BMC1 + BMC2
Lab analysis
Statistical Analysis
Signature 1
Source: Figure 11 G
Description: The genus-level comparison of fecal samples and caecum content samples
Abundance in Group 1: decreased abundance in Normal + Control + BMC1 + BMC2
| NCBI | Quality Control | Links |
|---|---|---|
| Ruminococcus |
Revision editor(s): Mautin
Experiment 90
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Normal + Control + BMCI + BMC2
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- C-Control + C-CBM1 + C-CBM2
Lab analysis
Statistical Analysis
Signature 1
Source: Figure 11 H
Description: The genus-level comparison of fecal samples and caecum content samples.
Abundance in Group 1: increased abundance in C-Control + C-CBM1 + C-CBM2
| NCBI | Quality Control | Links |
|---|---|---|
| Akkermansia.Akkermansia. |
Revision editor(s): Mautin
Contents
- 1 Experiment 1
- 2 Experiment 2
- 3 Experiment 3
- 4 Experiment 4
- 5 Experiment 5
- 6 Experiment 6
- 7 Experiment 7
- 8 Experiment 8
- 9 Experiment 9
- 10 Experiment 10
- 11 Experiment 11
- 12 Experiment 12
- 13 Experiment 13
- 14 Experiment 14
- 15 Experiment 15
- 16 Experiment 16
- 17 Experiment 17
- 18 Experiment 18
- 19 Experiment 19
- 20 Experiment 20
- 21 Experiment 21
- 22 Experiment 22
- 23 Experiment 23
- 24 Experiment 24
- 25 Experiment 25
- 26 Experiment 26
- 27 Experiment 27
- 28 Experiment 28
- 29 Experiment 29
- 30 Experiment 30
- 31 Experiment 31
- 32 Experiment 32
- 33 Experiment 33
- 34 Experiment 34
- 35 Experiment 35
- 36 Experiment 36
- 37 Experiment 37
- 38 Experiment 38
- 39 Experiment 39
- 40 Experiment 40
- 41 Experiment 41
- 42 Experiment 42
- 43 Experiment 43
- 44 Experiment 44
- 45 Experiment 45
- 46 Experiment 46
- 47 Experiment 47
- 48 Experiment 48
- 49 Experiment 49
- 50 Experiment 50
- 51 Experiment 51
- 52 Experiment 52
- 53 Experiment 53
- 54 Experiment 54
- 55 Experiment 55
- 56 Experiment 56
- 57 Experiment 57
- 58 Experiment 58
- 59 Experiment 59
- 60 Experiment 60
- 61 Experiment 61
- 62 Experiment 62
- 63 Experiment 63
- 64 Experiment 64
- 65 Experiment 65
- 66 Experiment 66
- 67 Experiment 67
- 68 Experiment 68
- 69 Experiment 69
- 70 Experiment 70
- 71 Experiment 71
- 72 Experiment 72
- 73 Experiment 73
- 74 Experiment 74
- 75 Experiment 75
- 76 Experiment 76
- 77 Experiment 77
- 78 Experiment 78
- 79 Experiment 79
- 80 Experiment 80
- 81 Experiment 81
- 82 Experiment 82
- 83 Experiment 83
- 84 Experiment 84
- 85 Experiment 85
- 86 Experiment 86
- 87 Experiment 87
- 88 Experiment 88
- 89 Experiment 89
- 90 Experiment 90
